Literature DB >> 21148349

Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension.

L Gabriel Navar1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21148349      PMCID： PMC3006411          DOI： 10.1152/japplphysiol.00182.2010a

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN： 0161-7567


× No keyword cloud information.
  26 in total

1.  Elements of a paracrine tubular renin-angiotensin system along the entire nephron.

Authors:  A Rohrwasser; T Morgan; H F Dillon; L Zhao; C W Callaway; E Hillas; S Zhang; T Cheng; T Inagami; K Ward; D A Terreros; J M Lalouel
Journal:  Hypertension       Date:  1999-12       Impact factor: 10.190

Review 2.  Epithelial sodium channel: mendelian versus essential hypertension.

Authors:  Bernard C Rossier; Laurent Schild
Journal:  Hypertension       Date:  2008-08-18       Impact factor: 10.190

3.  Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension.

Authors:  Murray Esler; Elisabeth Lambert; Markus Schlaich
Journal:  J Appl Physiol (1985)       Date:  2010-02-25

4.  Enhanced responses to ganglion blockade do not reflect sympathetic nervous system contribution to angiotensin II-induced hypertension.

Authors:  John-Luis Moretti; Sandra L Burke; Roger G Evans; Gavin W Lambert; Geoffrey A Head
Journal:  J Hypertens       Date:  2009-09       Impact factor: 4.844

5.  Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.

Authors:  G L Bakris; R D Toto; P A McCullough; R Rocha; D Purkayastha; P Davis
Journal:  Kidney Int       Date:  2008-03-19       Impact factor: 10.612

6.  Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice.

Authors:  Romer A Gonzalez-Villalobos; Dale M Seth; Ryousuke Satou; Heather Horton; Naro Ohashi; Kayoko Miyata; Akemi Katsurada; Duy V Tran; Hiroyuki Kobori; L G Navar
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-25

7.  Collecting duct renin is upregulated in both kidneys of 2-kidney, 1-clip goldblatt hypertensive rats.

Authors:  Minolfa C Prieto-Carrasquero; Fady T Botros; Javier Pagan; Hiroyuki Kobori; Dale M Seth; Dulce E Casarini; L Gabriel Navar
Journal:  Hypertension       Date:  2008-04-21       Impact factor: 10.190

8.  Enhanced distal nephron sodium reabsorption in chronic angiotensin II-infused mice.

Authors:  Di Zhao; Dale M Seth; L Gabriel Navar
Journal:  Hypertension       Date:  2009-06-01       Impact factor: 10.190

9.  Levels of renal and extrarenal sympathetic drive in angiotensin II-induced hypertension.

Authors:  Sandra L Burke; Roger G Evans; John-Luis Moretti; Geoffrey A Head
Journal:  Hypertension       Date:  2008-02-11       Impact factor: 10.190

10.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321
View more
  17 in total

1.  Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activated intrarenal renin-angiotensin system is correlated with high blood pressure in humans.

Authors:  Hiroyuki Kobori; Qi Fu; Steven D Crowley; Romer A Gonzalez-Villalobos; Ruy R Campos
Journal:  J Appl Physiol (1985)       Date:  2010-12

2.  Tautology vs. physiology in the etiology of hypertension.

Authors:  Daniel A Beard
Journal:  Physiology (Bethesda)       Date:  2013-09

3.  Should we be sympathetic to angiotensin II infusion?

Authors:  Michael A Hill; Gerald A Meininger
Journal:  J Physiol       Date:  2013-11-01       Impact factor: 5.182

4.  Comparative study of high dose mono-therapy of amlodipine or telmisartan, and their low dose combination in mild to moderate hypertension.

Authors:  Jaswant Goyal; Zafer Yab Khan; Prerna Upadhyaya; Barkha Goyal; Shipra Jain
Journal:  J Clin Diagn Res       Date:  2014-06-20

Review 5.  The roles of sensitization and neuroplasticity in the long-term regulation of blood pressure and hypertension.

Authors:  Alan Kim Johnson; Zhongming Zhang; Sarah C Clayton; Terry G Beltz; Seth W Hurley; Robert L Thunhorst; Baojian Xue
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-19       Impact factor: 3.619

Review 6.  Neural mechanisms of angiotensin II-salt hypertension: implications for therapies targeting neural control of the splanchnic circulation.

Authors:  John W Osborn; Gregory D Fink; Marcos T Kuroki
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

7.  ACE inhibitors and the risk of fractures: a meta-analysis of observational studies.

Authors:  Yan-Zhen Cheng; Zhen-Zi Huang; Ze-Feng Shen; Hai-Yang Wu; Jia-Xin Peng; Mary Miu Yee Waye; Shi-Tao Rao; Li Yang
Journal:  Endocrine       Date:  2016-12-19       Impact factor: 3.633

8.  Hyperglycaemia induced by chronic i.p. and oral glucose loading leads to hypertension through increased Na+ retention in proximal tubule.

Authors:  Selim Fakhruddin; Wael A Alanazi; Hussain N Alhamami; Karen P Briski; Keith E Jackson
Journal:  Exp Physiol       Date:  2017-12-07       Impact factor: 2.969

Review 9.  Blood Pressure: Return of the Sympathetics?

Authors:  Michael J Joyner; Jacqueline K Limberg
Journal:  Curr Hypertens Rep       Date:  2016-01       Impact factor: 5.369

10.  Intravital Förster resonance energy transfer imaging reveals elevated [Ca2+]i and enhanced sympathetic tone in femoral arteries of angiotensin II-infused hypertensive biosensor mice.

Authors:  Youhua Wang; Ling Chen; W Gil Wier; Jin Zhang
Journal:  J Physiol       Date:  2013-08-27       Impact factor: 5.182
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.